{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T06:18:59Z","timestamp":1788502739552,"version":"build-2803163510"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T00:00:00Z","timestamp":1638835200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Post-acute COVID-19 syndrome (PACS) is an emerging healthcare burden. The risk factors associated with PACS remain largely unclear. The aim of this study was to evaluate the frequency of new or persistent symptoms in COVID-19 patients post hospital discharge and identify associated risk factors.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Our prospective cohort comprised of PCR-confirmed COVID-19 patients admitted to King Fahad Medical City, Riyadh, Saudi Arabia between May and July 2020. The patients were interviewed through phone calls by trained physicians from 6 weeks up to 6 months post hospital discharge. Multivariate Cox proportional hazards and logistic regression models were used to examine for predictors associated with persistence of symptoms and non-return to baseline health.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>222 COVID-19 patients responded to follow-up phone interviews after a median of 122 days post discharge. The majority of patients were men (77%) with mean age of 52.47 (\u00b1 13.95) years. 56.3% of patients complained of persistent symptoms; 66 (29.7%) experiencing them for &gt;21 days and 64 (28.8%) reporting not having returned to their baseline health. Furthermore, 39 patients (17.6%) reported visiting an emergency room post discharge for COVID-19-related symptoms while 16 (7.2%) had required re-hospitalization. Shortness of breath (40.1%), cough (27.5%) and fatigue (29.7%) were the most frequently reported symptoms at follow-up. After multivariable adjustments, female gender, pre-existing hypertension and length of hospital stay were associated with an increased risk of new or persistent symptoms. Age, pre-existing lung disease and emergency room visits increased the likelihood of not fully recovering from acute COVID-19. Patients who were treated with interferon \u03b2-1b based triple antiviral therapy during hospital stay were less likely to experience new or persistent symptoms and more likely to return to their baseline health.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>COVID-19 survivors continued to suffer from dyspnea, cough and fatigue at 4 months post hospital discharge. Several risk factors could predict which patients are more likely to experience PACS and may benefit from individualized follow-up and rehabilitation programs.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0260568","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T18:28:46Z","timestamp":1638901726000},"page":"e0260568","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":93,"title":["Prevalence and predictors of Post-Acute COVID-19 Syndrome (PACS) after hospital discharge: A cohort study with 4 months median follow-up"],"prefix":"10.1371","volume":"16","author":[{"given":"Imad M.","family":"Tleyjeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4682-5927","authenticated-orcid":true,"given":"Basema","family":"Saddik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4634-4952","authenticated-orcid":true,"given":"Nourah","family":"AlSwaidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"AlAnazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2991-3802","authenticated-orcid":true,"given":"Rakhee K.","family":"Ramakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deema","family":"Alhazmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Aloufi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9769-8147","authenticated-orcid":true,"given":"Fahad","family":"AlSumait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Berbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabih","family":"Halwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,12,7]]},"reference":[{"issue":"4","key":"pone.0260568.ref001","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","article-title":"Post-acute COVID-19 syndrome","volume":"27","author":"A Nalbandian","year":"2021","journal-title":"Nature medicine"},{"key":"pone.0260568.ref002","doi-asserted-by":"crossref","first-page":"110195","DOI":"10.1016\/j.biopha.2020.110195","article-title":"New understanding of the damage of SARS-CoV-2 infection outside the respiratory system","volume":"127","author":"Y Zhang","year":"2020","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"issue":"14","key":"pone.0260568.ref003","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1001\/jama.2020.2565","article-title":"Presumed Asymptomatic Carrier Transmission of COVID-19","volume":"323","author":"Y Bai","year":"2020","journal-title":"Jama"},{"issue":"6","key":"pone.0260568.ref004","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.2020.12603","article-title":"Persistent Symptoms in Patients After Acute COVID-19","volume":"324","author":"A Carf\u00ec","year":"2020","journal-title":"Jama"},{"key":"pone.0260568.ref005","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijid.2020.03.020","article-title":"Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19)","volume":"94","author":"H Nishiura","year":"2020","journal-title":"International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases"},{"issue":"2574","key":"pone.0260568.ref006","article-title":"Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19","volume":"12","author":"RK Ramakrishnan","year":"2021","journal-title":"Frontiers in Immunology"},{"key":"pone.0260568.ref007","first-page":"m4938","article-title":"NICE guideline on long covid","volume":"371","author":"M Sivan","year":"2020","journal-title":"BMJ (Clinical research ed)"},{"key":"pone.0260568.ref008","unstructured":"Sant\u00e9 HAd. Covid-19: diagnostiquer et prendre en charge les adultes pr\u00e9sentant des sympt\u00f4mes prolong\u00e9s. 2021 [Available from: https:\/\/www.has-sante.fr\/jcms\/p_3237458\/fr\/covid-19-diagnostiquer-et-prendre-en-charge-les-adultespresentant-des-symptomes-prolonges."},{"key":"pone.0260568.ref009","first-page":"m3026","article-title":"Management of post-acute covid-19 in primary care","volume":"370","author":"T Greenhalgh","year":"2020","journal-title":"BMJ (Clinical research ed)"},{"key":"pone.0260568.ref010","first-page":"n136","article-title":"Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline","volume":"372","author":"W Shah","year":"2021","journal-title":"BMJ (Clinical research ed)"},{"issue":"2","key":"pone.0260568.ref011","doi-asserted-by":"crossref","first-page":"e210830","DOI":"10.1001\/jamanetworkopen.2021.0830","article-title":"Sequelae in Adults at 6 Months After COVID-19 Infection","volume":"4","author":"JK Logue","year":"2021","journal-title":"JAMA network open"},{"issue":"30","key":"pone.0260568.ref012","doi-asserted-by":"crossref","first-page":"993","DOI":"10.15585\/mmwr.mm6930e1","article-title":"Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network\u2014United States, March-June 2020","volume":"69","author":"MW Tenforde","year":"2020","journal-title":"MMWR Morbidity and mortality weekly report"},{"issue":"19","key":"pone.0260568.ref013","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19","volume":"382","author":"B Cao","year":"2020","journal-title":"The New England journal of medicine"},{"issue":"10270","key":"pone.0260568.ref014","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0140-6736(20)32656-8","article-title":"6-month consequences of COVID-19 in patients discharged from hospital: a cohort study","volume":"397","author":"C Huang","year":"2021","journal-title":"Lancet (London, England)"},{"key":"pone.0260568.ref015","article-title":"High-dimensional characterization of post-acute sequalae of COVID-19","author":"Z Al-Aly","year":"2021","journal-title":"Nature"},{"key":"pone.0260568.ref016","article-title":"Medium-term outcome of severe to critically ill patients with SARS-CoV-2 infection","author":"N Gautam","year":"2021","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"15","key":"pone.0260568.ref017","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1001\/jama.2021.3331","article-title":"Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19","volume":"325","author":"L Morin","year":"2021","journal-title":"Jama"},{"key":"pone.0260568.ref018","article-title":"Long-term outcomes of patients following hospitalization for coronavirus disease 2019: a prospective observational study","author":"Y Meije","year":"2021","journal-title":"Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases"},{"key":"pone.0260568.ref019","article-title":"More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis","author":"S Lopez-Leon","year":"2021","journal-title":"medRxiv: the preprint server for health sciences"},{"issue":"4","key":"pone.0260568.ref020","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41591-021-01292-y","article-title":"Attributes and predictors of long COVID","volume":"27","author":"CH Sudre","year":"2021","journal-title":"Nature medicine"},{"issue":"2","key":"pone.0260568.ref021","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/jmv.26368","article-title":"Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation","volume":"93","author":"SJ Halpin","year":"2021","journal-title":"Journal of medical virology"},{"issue":"1","key":"pone.0260568.ref022","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cmi.2020.09.023","article-title":"Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study","volume":"27","author":"Q Xiong","year":"2021","journal-title":"Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases"},{"issue":"11","key":"pone.0260568.ref023","doi-asserted-by":"crossref","first-page":"e0240784","DOI":"10.1371\/journal.pone.0240784","article-title":"Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection","volume":"15","author":"L Townsend","year":"2020","journal-title":"PloS one"},{"key":"pone.0260568.ref024","article-title":"Estimating the burden of post-COVID-19 syndrome in a population-based cohort study of SARS-CoV-2 infected individuals: Implications for healthcare service planning","author":"D Menges","year":"2021","journal-title":"medRxiv: the preprint server for health sciences"},{"issue":"3","key":"pone.0260568.ref025","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.yfrne.2014.04.004","article-title":"Gender differences in autoimmune disease","volume":"35","author":"ST Ngo","year":"2014","journal-title":"Frontiers in neuroendocrinology"},{"issue":"4","key":"pone.0260568.ref026","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines8040700","article-title":"Immunogenetic Association Underlying Severe COVID-19","volume":"8","author":"K McCoy","year":"2020","journal-title":"Vaccines"},{"issue":"2","key":"pone.0260568.ref027","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S2213-2600(20)30511-7","article-title":"Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"9","author":"PD Monk","year":"2021","journal-title":"The Lancet Respiratory medicine"},{"issue":"6515","key":"pone.0260568.ref028","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Q Zhang","year":"2020","journal-title":"Science (New York, NY)"},{"issue":"6","key":"pone.0260568.ref029","doi-asserted-by":"crossref","DOI":"10.3390\/v12060628","article-title":"Broad-Spectrum Host-Based Antivirals Targeting the Interferon and Lipogenesis Pathways as Potential Treatment Options for the Pandemic Coronavirus Disease 2019 (COVID-19)","volume":"12","author":"S Yuan","year":"2020","journal-title":"Viruses"},{"issue":"12","key":"pone.0260568.ref030","doi-asserted-by":"crossref","first-page":"e0243597","DOI":"10.1371\/journal.pone.0243597","article-title":"Transmissibility of COVID-19 depends on the viral load around onset in adult and symptomatic patients","volume":"15","author":"H Kawasuji","year":"2020","journal-title":"PloS one"},{"key":"pone.0260568.ref031","article-title":"Post-acute conditions of patients with COVID-19 not requiring hospital admission","author":"L Huang","year":"2021","journal-title":"The Lancet Infectious diseases"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0260568","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T18:29:21Z","timestamp":1638901761000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0260568"}},"subtitle":[],"editor":[{"given":"Robert Jeenchen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,12,7]]},"references-count":31,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0260568","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,7]]}}}